User profiles for M. Salmona

Mario Salmona

- Verified email at marionegri.it - Cited by 25152

Michelle Salmona

- Verified email at pobox.com - Cited by 1103

Qualitative research in finance

D Kaczynski, M Salmona… - Australian Journal of …, 2014 - journals.sagepub.com
This paper provides an overview of qualitative research to encourage finance researchers
to apply a more diverse approach to current research practices. Social science researchers …

[HTML][HTML] Safety and toxicology of magnolol and honokiol

A Sarrica, N Kirika, M Romeo, M Salmona… - Planta …, 2018 - thieme-connect.com
… No mutagenic activity was observed with the Ames test on four bacterial strains of Salmonella
typhimurium (TA98, TA100, TA1535 and TA1537) and a strain of Escherichia coli (WP2 uvr…

Neurotoxicity of a prion protein fragment

…, N Angeretti, R Chiesa, E Monzani, M Salmona… - Nature, 1993 - nature.com
THE cellular prion protein (PrP c ) is a sialoglycoprotein of M r 33–35K that is expressed
predominantly in neurons 1–3 . In transmissible and genetic neurodegenerative disorders such …

Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes

…, M Salmona, V Bonetto, M Mengozzi… - Proceedings of the …, 2002 - National Acad Sciences
Formation of mixed disulfides between glutathione and the cysteines of some proteins (glutathionylation)
has been suggested as a mechanism through which protein functions can be …

A new face for old antibiotics: tetracyclines in treatment of amyloidoses

…, G Forloni, F Tagliavini, M Salmona - Journal of medicinal …, 2013 - ACS Publications
The use of tetracyclines has declined because of the appearance of resistant bacterial strains.
However, the indications of nonantimicrobial activities of these drugs have considerably …

Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

…, R Chiesa, M Gobbi, M Salmona… - Proceedings of the …, 2010 - National Acad Sciences
Inability to form new memories is an early clinical sign of Alzheimer’s disease (AD). There is
ample evidence that the amyloid-β (Aβ) peptide plays a key role in the pathogenesis of this …

[HTML][HTML] Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum …

…, A Tagliabue, M Salmona, F Tedesco, M Introna… - Journal of Biological …, 1997 - ASBMB
PTX3 is a prototypic long pentraxin consisting of a C-terminal 203-amino acid pentraxin-like
domain coupled with an N-terminal 178-amino acid unrelated portion. The present study …

A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis

…, L Cantù, E Del Favero, E Levy, M Salmona… - Science, 2009 - science.org
β-Amyloid precursor protein (APP) mutations cause familial Alzheimer's disease with nearly
complete penetrance. We found an APP mutation [alanine-673→valine-673 (A673V)] that …

[HTML][HTML] Inhibition of monocyte chemotactic protein-1 synthesis by statins

…, P Fruscella, M Salmona, A Vecchi, M Pinza… - Laboratory …, 2000 - nature.com
… in a 20 mm imidazole solution, pH 7.4, containing 5 mm … μm of [ 14 C]HMG-CoA in a 40
mm D-glucose-6-phosphate solution containing 12 mm dithiothreitol, 4 mm NADPH, and 10 mm

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

…, M Bianchi, P Fruscella, M Salmona - … , and vascular biology, 2001 - Am Heart Assoc
This study set out to clarify whether the inhibition of sterol or nonsterol derivatives arising from
mevalonate biotransformation plays a major role in the in vivo anti-inflammatory action of …